Quoin Pharmaceuticals Ltd DRC (QNRX) — Cash Flow-to-Debt Ratio
Quoin Pharmaceuticals Ltd DRC (QNRX) has a Cash Flow-to-Debt Ratio of -0.70x as of March 2026, meaning its operating cash flow of $-4.87 Million could theoretically repay -1% of its total liabilities ($6.92 Million) in one year. See working capital to net assets of Quoin Pharmaceuticals Ltd DRC to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Quoin Pharmaceuticals Ltd DRC Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Quoin Pharmaceuticals Ltd DRC across 11 annual periods. Also explore Quoin Pharmaceuticals Ltd DRC net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Quoin Pharmaceuticals Ltd DRC (2015–2025)
Year-by-year debt coverage analysis for Quoin Pharmaceuticals Ltd DRC. For market capitalisation and broader financial context, see Quoin Pharmaceuticals Ltd DRC stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1862.42x | $-13.54 Billion | $7.27 Million | ▼ -154079.9% |
| 2024 | -1.21x | $-7.86 Million | $6.50 Million | ▲ +0.1% |
| 2023 | -1.21x | $-7.86 Million | $6.51 Million | ▼ -0.5% |
| 2022 | -1.20x | $-8.48 Million | $7.05 Million | ▼ -82.9% |
| 2021 | -0.66x | $-5.72 Million | $8.70 Million | ▼ -292.2% |
| 2020 | -0.17x | $-1.34 Million | $7.99 Million | ▲ +94.5% |
| 2019 | -3.04x | $-5.71 Million | $1.88 Million | ▲ +16.9% |
| 2018 | -3.66x | $-6.57 Million | $1.80 Million | ▼ -143.8% |
| 2017 | -1.50x | $-4.98 Million | $3.32 Million | ▲ +43.9% |
| 2016 | -2.67x | $-3.77 Million | $1.41 Million | ▲ +1.0% |
| 2015 | -2.70x | $-1.98 Million | $735.02K | — |